标题
Dendritic Cells and Cancer: From Biology to Therapeutic Intervention
作者
关键词
-
出版物
Cancers
Volume 11, Issue 4, Pages 521
出版商
MDPI AG
发表日期
2019-04-12
DOI
10.3390/cancers11040521
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
- (2018) M E Rodríguez-Ruiz et al. ANNALS OF ONCOLOGY
- TIM-3 Regulates CD103 + Dendritic Cell Function and Response to Chemotherapy in Breast Cancer
- (2018) Álvaro de Mingo Pulido et al. CANCER CELL
- Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling
- (2018) Mariana Terra et al. CANCER RESEARCH
- Intratumoral CpG-B promotes anti-tumoral neutrophil, cDC, and T cell cooperation without reprograming tolerogenic pDC
- (2018) Marion Humbert et al. CANCER RESEARCH
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Chemokine and chemotactic signals in dendritic cell migration
- (2018) Laura Tiberio et al. Cellular & Molecular Immunology
- Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c + CD103 + Monocytic Antigen-Presenting Cells in Tumors
- (2018) Madhav D. Sharma et al. IMMUNITY
- Next generation of immune checkpoint therapy in cancer: new developments and challenges
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Tumor Dendritic Cells (DCs) Derived from Precursors of Conventional DCs Are Dispensable for Intratumor CTL Responses
- (2018) Jun Diao et al. JOURNAL OF IMMUNOLOGY
- Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
- (2018) C Schütz et al. LEUKEMIA
- Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
- (2018) Paula Michea et al. NATURE IMMUNOLOGY
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- CD103+ Cell Growth Factor Flt3L Enhances the Efficacy of Immune Checkpoint Blockades in Murine Glioblastoma Model
- (2018) Xiaolin Miao et al. ONCOLOGY RESEARCH
- Human in vivo -differentiated monocyte-derived dendritic cells
- (2018) Tsing-Lee Tang-Huau et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Nitric Oxide Signaling in T Cell-Mediated Immunity
- (2018) Almudena García-Ortiz et al. TRENDS IN MOLECULAR MEDICINE
- Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
- (2018) Melissa A. Meyer et al. Nature Communications
- Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway
- (2018) Tsing-Lee Tang-Huau et al. Nature Communications
- BRAF inhibitors stimulate inflammasome activation and interleukin 1 beta production in dendritic cells
- (2018) Eva Hajek et al. Oncotarget
- Current Concepts of Antigen Cross-Presentation
- (2018) Maria Embgenbroich et al. Frontiers in Immunology
- STINGing the Tumor's immune evasion mechanism
- (2018) Young J. Kim OncoImmunology
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs
- (2018) Enguang Bi et al. JOURNAL OF CLINICAL INVESTIGATION
- Recent clinical trends in Toll-like receptor targeting therapeutics
- (2018) Muhammad Ayaz Anwar et al. MEDICINAL RESEARCH REVIEWS
- Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
- (2018) Zachary S. Buchwald et al. Frontiers in Oncology
- High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization
- (2017) Marcela Alcántara-Hernández et al. IMMUNITY
- Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
- (2017) Andrés Alloatti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
- (2017) Jianjun Gao et al. NATURE MEDICINE
- Mapping the human DC lineage through the integration of high-dimensional techniques
- (2017) Peter See et al. SCIENCE
- Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
- (2017) Alexandra-Chloé Villani et al. SCIENCE
- Dendritic cell subsets
- (2017) Christophe Macri et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer
- (2017) Filippo Veglia et al. Nature Communications
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Interleukin-12 from CD103 + Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of Metastasis
- (2017) Deepak Mittal et al. Cancer Immunology Research
- Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells
- (2017) Alessandra Fragale et al. Cancer Immunology Research
- A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
- (2017) Jeremy B. Foote et al. Cancer Immunology Research
- Transcriptional Control of Dendritic Cell Development
- (2016) Theresa L. Murphy et al. Annual Review of Immunology
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines
- (2016) G. Bakdash et al. CANCER RESEARCH
- Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells
- (2016) E. Beyranvand Nejad et al. CANCER RESEARCH
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- The transcription factor Zeb2 regulates development of conventional and plasmacytoid DCs by repressing Id2
- (2016) Charlotte L. Scott et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy
- (2016) Man Liu et al. JOURNAL OF PATHOLOGY
- Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma
- (2016) Yuta Kondo et al. ORAL ONCOLOGY
- Influences of BRAF Inhibitors on the Immune Microenvironment and the Rationale for Combined Molecular and Immune Targeted Therapy
- (2016) Sangeetha M. Reddy et al. Current Oncology Reports
- The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
- (2016) Damya Laoui et al. Nature Communications
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells
- (2015) Kristian M Hargadon et al. IMMUNOLOGY AND CELL BIOLOGY
- Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells
- (2015) A Ray et al. LEUKEMIA
- Batf3 maintains autoactivation of Irf8 for commitment of a CD8α+ conventional DC clonogenic progenitor
- (2015) Gary E Grajales-Reyes et al. NATURE IMMUNOLOGY
- STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
- (2015) Olivier Demaria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
- (2015) E. Vacchelli et al. SCIENCE
- STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
- (2015) Juan Fu et al. Science Translational Medicine
- Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
- (2015) S. Van Lint et al. Cancer Immunology Research
- Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
- (2015) Erika Héninger et al. Frontiers in Immunology
- Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors
- (2015) Alexander Pedroza-Gonzalez et al. OncoImmunology
- PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity
- (2015) Tong Seng Lim et al. OncoImmunology
- Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103−and XCR1+CD103+dendritic cells
- (2015) Ben Wylie et al. OncoImmunology
- Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1
- (2014) H. Won et al. BLOOD
- Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
- (2014) Brian Ruffell et al. CANCER CELL
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
- (2014) Sandra Van Lint et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Abstract 4573: STINGVAX - A novel tumor vaccine with cyclic dinucleotides - can induce potent anti-tumor responsesin vivo.
- (2014) Thomas W. Dubensky et al. CANCER RESEARCH
- VISTA Regulates the Development of Protective Antitumor Immunity
- (2014) I. Le Mercier et al. CANCER RESEARCH
- Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
- (2014) H. Okada et al. CLINICAL CANCER RESEARCH
- Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy
- (2014) Alison M. McDonnell et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Vaccine adjuvant uses of poly-IC and derivatives
- (2014) Karen AO Martins et al. Expert Review of Vaccines
- Cutting Edge: Cooperation of IPS-1- and TRIF-Dependent Pathways in Poly IC-Enhanced Antibody Production and Cytotoxic T Cell Responses
- (2014) H. Kumar et al. JOURNAL OF IMMUNOLOGY
- Alternative Activation of Human Plasmacytoid DCs In Vitro and in Melanoma Lesions: Involvement of LAG-3
- (2014) Chiara Camisaschi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes
- (2014) F. H. W. Shand et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cellular and molecular origin of tumor-associated macrophages
- (2014) R. A. Franklin et al. SCIENCE
- VISTA Is a Novel Broad-Spectrum Negative Checkpoint Regulator for Cancer Immunotherapy
- (2014) J. L. Lines et al. Cancer Immunology Research
- Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14+PD-L1+phenotype in prostate cancer
- (2014) Lisa K Spary et al. OncoImmunology
- Role of plasmacytoid dendritic cells and inducible costimulator-positive regulatory T cells in the immunosuppression microenvironment of gastric cancer
- (2013) Xiao-Mei Huang et al. CANCER SCIENCE
- Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation
- (2013) Elodie Segura et al. IMMUNITY
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells
- (2013) Vanja Sisirak et al. INTERNATIONAL JOURNAL OF CANCER
- KLF4 Modulates Expression of IL-6 in Dendritic Cells via Both Promoter Activation and Epigenetic Modification
- (2013) Jason M. Rosenzweig et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modulation of Regulatory T Cell Function by Monocyte-Derived Dendritic Cells Matured through Electroporation with mRNA Encoding CD40 Ligand, Constitutively Active TLR4, and CD70
- (2013) J. J. Pen et al. JOURNAL OF IMMUNOLOGY
- Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial
- (2013) Fiona Bath-Hextall et al. LANCET ONCOLOGY
- Inflammatory dendritic cells in mice and humans
- (2013) Elodie Segura et al. TRENDS IN IMMUNOLOGY
- Plasmacytoid Dendritic Cells Support Melanoma Progression by Promoting Th2 and Regulatory Immunity through OX40L and ICOSL
- (2013) C. Aspord et al. Cancer Immunology Research
- An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
- (2013) E. B. Golden et al. Cancer Immunology Research
- Immunogenic cell death in radiation therapy
- (2013) Lorenzo Galluzzi et al. OncoImmunology
- ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells
- (2012) J. Faget et al. CANCER RESEARCH
- Impaired IFN- Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression
- (2012) V. Sisirak et al. CANCER RESEARCH
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3+ T-Regulatory Cells
- (2012) C. Conrad et al. CANCER RESEARCH
- Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
- (2012) S. Adams et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
- (2012) P. Sabbatini et al. CLINICAL CANCER RESEARCH
- Global mapping of H3K4me3 and H3K27me3 reveals chromatin state-based regulation of human monocyte-derived dendritic cells in different environments
- (2012) Y Huang et al. GENES AND IMMUNITY
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis
- (2012) Sana Intidhar Labidi-Galy et al. OncoImmunology
- Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient
- (2011) An M. T. Van Nuffel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer
- (2011) S. I. Labidi-Galy et al. CANCER RESEARCH
- Anti-TIM3 Antibody Promotes T Cell IFN- -Mediated Antitumor Immunity and Suppresses Established Tumors
- (2011) S. F. Ngiow et al. CANCER RESEARCH
- FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines
- (2011) S. Kreiter et al. CANCER RESEARCH
- Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice
- (2011) W. Joost Lesterhuis et al. JOURNAL OF CLINICAL INVESTIGATION
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
- (2011) Li Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: Expression of XCR1 Defines Mouse Lymphoid-Tissue Resident and Migratory Dendritic Cells of the CD8 + Type
- (2011) K. Crozat et al. JOURNAL OF IMMUNOLOGY
- Immunomodulation by Imiquimod in Patients with High-Risk Primary Melanoma
- (2011) Rupa Narayan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- Tolerogenic plasmacytoid DC
- (2010) Benjamin M. Matta et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Human CD141+(BDCA-3)+dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
- (2010) Sarah L. Jongbloed et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+cells as homologues of mouse CD8+dendritic cells
- (2010) Annabell Bachem et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mouse CD8α+DCs and human BDCA3+DCs are major producers of IFN-λ in response to poly IC
- (2010) Henning Lauterbach et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Resident and Monocyte-Derived Dendritic Cells Become Dominant IL-12 Producers under Different Conditions and Signaling Pathways
- (2010) Y. Zhan et al. JOURNAL OF IMMUNOLOGY
- Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy
- (2010) Sara M. Mangsbo et al. JOURNAL OF IMMUNOTHERAPY
- First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
- (2010) Chrystelle Brignone et al. Journal of Translational Medicine
- Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8+ T cell responses to influenza
- (2010) André Ballesteros-Tato et al. NATURE IMMUNOLOGY
- Lipid accumulation and dendritic cell dysfunction in cancer
- (2010) Donna L Herber et al. NATURE MEDICINE
- Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
- (2009) M. A. Curran et al. CANCER RESEARCH
- The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
- (2009) J. Ozao-Choy et al. CANCER RESEARCH
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
- (2009) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- Tumour-derived prostaglandin E2and transforming growth factor-β synergize to inhibit plasmacytoid dendritic cell-derived interferon-α
- (2009) Isabelle Bekeredjian-Ding et al. IMMUNOLOGY
- The origin and development of nonlymphoid tissue CD103+DCs
- (2009) Florent Ginhoux et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells
- (2009) Stephen McCartney et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dendritic cells require a systemic type I interferon response to mature and induce CD4+Th1 immunity with poly IC as adjuvant
- (2009) M. Paula Longhi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Recruitment and Differentiation of Conventional Dendritic Cell Precursors in Tumors
- (2009) J. Diao et al. JOURNAL OF IMMUNOLOGY
- LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis
- (2009) C. J. Workman et al. JOURNAL OF IMMUNOLOGY
- Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses
- (2009) Hideki Nakano et al. NATURE IMMUNOLOGY
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection
- (2009) J. R. Aldridge et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses
- (2008) M. M. Hipp et al. BLOOD
- The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement
- (2008) I. Caminschi et al. BLOOD
- Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery
- (2008) Tomoki Ito et al. IMMUNITY
- Antigen-Presentation Properties of Plasmacytoid Dendritic Cells
- (2008) José A. Villadangos et al. IMMUNITY
- Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
- (2008) David Sancho et al. JOURNAL OF CLINICAL INVESTIGATION
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
- (2008) Mirjam Kool et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA
- (2008) Aude Bonehill et al. MOLECULAR THERAPY
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now